Growth Metrics

CVRx (CVRX) Treasury Shares (2020 - 2026)

CVRx's quarterly Treasury Shares came in at $602000.0 in Q1 2026, up 80.17% year-on-year from $334128.0 in Q1 2025, and up 57.07% quarter-over-quarter from $383268.0 in Q4 2025.

CVRx has reported Treasury Shares for 3 years, with the latest figure at $602000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Treasury Shares rose 80.17% year-over-year to $602000.0; the trailing twelve-month figure through Mar 2026 stood at $602000.0 (up 80.17% YoY), and the FY2025 full-year result was $383268.0, changed N/A from the prior year.
  • Treasury Shares for Q1 2026 stood at $602000.0, up from $383268.0 in the prior quarter.
  • The five-year high for Treasury Shares was $602000.0 in Q1 2026, with the low at $334128.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 256.42 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.51 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 325.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 900,000.00
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn 602,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 602,000.00
Mar 31, 2026 602,000.00
Dec 31, 2025 383,268.00
Dec 31, 2025 383,268.00
Sep 30, 2025 351,638.00
Sep 30, 2025 351,638.00
Jun 30, 2025 335,658.00
Jun 30, 2025 335,658.00
Mar 31, 2025 334,128.00
Mar 31, 2025 334,128.00
Dec 31, 2020 123,694.00
Dec 31, 2020 123,694.00
Sep 30, 2020 123,694.00
Sep 30, 2020 123,694.00
Jun 30, 2020 123,694.00
Jun 30, 2020 123,694.00